glp-1 eye rot Has Ozempic affected vision in retinitis pigmentosa patients? Focus on GLP-1 drugs &

Description

Injectables: GLP-1 and GIP/GLP-1 RAs versus basal insulin Randomised controlled trials (RTCs) have demonstrated that both semaglutide (Aroda et al, 2017) and tirzepatide (Ludvik et al, 2021

Recent research has highlighted the therapeutic potential of glucagon-like peptide-1 receptor agonists (GLP-1RAs) beyond glucose metabolism, particularly in neurodegenerative diseases such as Alzheimers disease (AD)

For the first time in years, Massarone boarded a plane without hiding cocaine in her luggage or sneaking a hit mid-flight in a restroom

doi: 10.2337/diacare.27.11.2628 [DOI] [PubMed] [Google Scholar] 53

GLP-1 RA glucagon-like peptide 1 receptor agonists, CI confidence interval, MACE major adverse cardiovascular event, MI myocardial infarction, SBP systolic blood pressure in mmHg, HR hazard ratio, RR relative risk, HF heart failure, LVEF left-ventricular ejection fraction a Primary or secondary outcome of interest as reported by the study Statistically significant confidence interval Major Adverse Cardiac Events Among Patients with T2DM Strong evidence supports using GLP-1 RAs to reduce MACE among patients with T2DM and established CVD